Jeff Aronin is a bioscience entrepreneur who built and has sold several successful biotech companies. He has earned a record number of novel drug approvals that improve the lives of patients and is known for innovating, developing and commercializing scientific discoveries in areas of high need, such as neurology.

In 2017, Jeff founded Paragon Biosciences, where he is chairman and chief executive officer. Paragon is among the life science industry’s most successful company creators, investing billions with its partners, to build companies that improve patient lives through advanced biotechnology.

Paragon has several growing companies such as Harmony Biosciences (NASDAQ: HRMY), Emalex Biosciences and CiRC Biosciences.

Jeff sits on corporate and civic boards including The Aspen Institute and the Weizmann Institute of Science and served 14 years as a Discover Financial Services board member.